市场调查报告书
商品编码
1468540
2024-2032 年按材料(氧化铝、氧化锆等)、生物相容性(生物惰性、生物活性、生物可吸收)、应用(牙科护理、骨科等)和地区分類的生物陶瓷市场报告Bioceramics Market Report by Material (Alumina, Zirconia, and Others), Biocompatibility (Bio-inert, Bio-active, Bio-resorbable), Application (Dental Care, Orthopedics, and Others), and Region 2024-2032 |
2023年全球生物陶瓷市场规模达180亿IMARC Group。
生物陶瓷是指陶瓷材料的一个子类,用于修復和替换肌肉骨骼系统患病和受损的部分。用于生产生物陶瓷的一些常用材料包括生物活性玻璃、可吸收磷酸钙、羟基磷灰石等。惰性。因此,生物陶瓷被用于骨科承重涂层、植牙、骨移植替代品和骨水泥等多种应用,例如矫正慢性脊椎弯曲、对齐和修復骨折、治疗先天畸形等。
为了提高患者身体的接受度并降低术后感染的发生率,对生物相容性材料的需求不断增加,这主要推动了全球生物陶瓷市场的发展。此外,肌肉骨骼疾病的发生率不断上升,包括骨质疏鬆症、骨关节炎、类风湿性关节炎、背部和颈部疼痛等,尤其是老年人群,也为全球市场创造了积极的前景。除此之外,医生在关节置换术中进行早期手术介入的新兴趋势正在推动膝关节、肩关节和髋关节植入物的使用,进而推动市场成长。此外,食物消费模式的变化以及饮食中营养的缺乏导致蛀牙形成和牙齿健康恶化的病例增加。这反过来又导致对牙冠、牙桥和刷毛的需求不断增加,最终导致生物陶瓷在牙科护理中的渗透率不断上升。此外,碳生物陶瓷因其轻质特性而日益普及,为患者和外科医生在植体定位方面提供了便利,也是一个重要的生长诱导因素。除此之外,包括氧化锆增韧氧化铝和磷酸钙涂层在内的新型先进材料的引入预计将满足未来几年全球生物陶瓷市场的成长。
The global bioceramics market size reached US$ 18.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 30.9 Billion by 2032, exhibiting a growth rate (CAGR) of 6% during 2024-2032.
Bioceramics refers to a subclass of ceramic materials that are used to repair and replace diseased and damaged parts of the musculoskeletal system. Some of the commonly available materials utilized in the production of bioceramics include bioactive glass, resorbable calcium phosphates, hydroxyapatite, etc. Additionally, they have certain beneficial characteristics, including biocompatibility, non-toxicity, dimensional stability, and chemical inertness. As a result, bioceramics are used in orthopedic load-bearing coatings, dental implants, bone graft substitutes, and bone cement for several applications, such as correcting chronic spinal curvature, aligning and repairing fractures, treating congenital deformities, etc.
The escalating requirement for biocompatible materials to increase acceptance by the patients' bodies, as well as lower the occurrence of post-surgery infections is primarily driving the global bioceramics market. Moreover, the growing incidences of musculoskeletal conditions, including osteoporosis, osteoarthritis, rheumatoid arthritis, back and neck pain, etc., especially among the geriatric population, are also creating a positive outlook for the global market. Besides this, the emerging trend of early surgical intervention by doctors in case of joint replacements is fueling the utilization of knee, shoulder, and hip implants, which in turn, is propelling the market growth. Furthermore, the changing food consumption patterns along with the lack of nutrition in diet have resulted in the increasing cases of cavity formation and deteriorated dental health. This, in turn, has led to the elevating need for crowns, bridges, and bristles, eventually contributing to the rising penetration of bioceramics in dental care. Additionally, the escalating popularity of carbon bioceramics owing to its lightweight nature, which offers convenience to patients and surgeons in terms of implant positioning, is also acting as a significant growth-inducing factor. Apart from this, the introduction of new advanced materials, including zirconia toughened alumina and calcium phosphate coatings, is projected to cater to the growth of the global bioceramics market in the coming years.
IMARC Group provides an analysis of the key trends in each sub-segment of the global bioceramics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on material, biocompatibility and application.
Alumina
Zirconia
Others
Bio-inert
Bio-active
Bio-resorbable
Dental Care
Orthopedics
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being CAM Bioceramics B.V., Carborundum Universal Limited (Murugappa Group), CeramTec GmbH, CoorsTek Inc., Dentsply Sirona, Koninklijke DSM N.V., Straumann and Stryker Corporation.